Eukles Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Eukles Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19	Closed	-$10.1K	–	248
2023 Q4	$10.1K	Hold	19	–	–	﹤0.01%	149
2023 Q3	$9.62K	Hold	19	–	–	0.01%	153
2023 Q2	$9.91K	Hold	19	–	–	0.01%	148
2023 Q1	$11K	Hold	19	–	–	0.01%	140
2022 Q4	$10K	Hold	19	–	–	0.01%	142
2022 Q3	$10K	Hold	19	–	–	0.01%	140
2022 Q2	$10K	Hold	19	–	–	0.01%	137
2022 Q1	$11K	Hold	19	–	–	0.01%	137
2021 Q4	$13K	Hold	19	–	–	0.01%	136
2021 Q3	$11K	Hold	19	–	–	0.01%	139
2021 Q2	$10K	Hold	19	–	–	0.01%	171
2021 Q1	$9K	Buy	+19	New	+$9.07K	0.01%	138

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Eukles Asset Management's TMO Position: Q1 2024 in Review

Eukles Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 19 shares — an estimated $10.1K sold.

Eukles Asset Management first reported a position in TMO in Q1 2021 and held it in 12 quarters. The position peaked at $13K in Q4 2021. 2,534 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

Eukles Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
Eukles Asset Management sold 19 Thermo Fisher Scientific shares in Q1 2024, an estimated $10.1K.
Eukles Asset Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 12 quarters.
Eukles Asset Management's Thermo Fisher Scientific position peaked at $13K in Q4 2021.
2,534 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Eukles Asset Management's 13F filing for Q1 2024, filed 13 May 2024.